ARVN
ARVN
NASDAQ · Pharmaceuticals

Arvinas Inc

$8.50
+0.20 (+2.41%)
As of Sep 22, 2:20 PM ET ·
Analyst Consensus
Buy
23
Analysts
High
Coverage
Buy 13 57%
Hold 9 39%
Sell 1 4%
Price Target
Analyst Price Target +679.1% upside
Low Target $44.47
Average Target $66.22
High Target $75.30
Current Price $8.50
Current
$8.50
Target
$66.22
$44.47 $66.22 avg $75.30
Scenario Analysis
Bear Case
$44.47
423.2%
Low target
Base Case
$66.22
+679.1%
Avg target
Bull Case
$75.30
+785.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$14.51
-41.4% from high
52-Week Low
$6.97
+22.0% from low
Target vs 52W High
$66.22
+356.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.8%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.1%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.0%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.6%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +187.5%